Prospect News: News for Jazz Financing Lux Sarl

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with J > Issuers starting with J, HY only > All stories on Jazz Financing Lux Sarl > Stories on Jazz Financing Lux Sarl, HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Jazz Financing Lux Sarl

12/11/2024	BKCVHY	Moody’s lifts Jazz Pharmaceuticals
6/20/2024	CLHY	Market Commentary: Jazz Pharmaceuticals, ModivCare break; Carroll County, Marlink, Frontier, Action updated
6/13/2024	BKCVHY	S&P assigns BB- to Jazz Financing Lux loan
1/25/2024	BKCVHY	Moody’s upgrades Jazz Pharmaceuticals
1/8/2024	CLHY	Market Commentary: Zelis, Clarios tweak deals; Inspire, Citadel, Caliber, Jane, DirecTV and more set talk
4/9/2021	BKCVHY	Moody's gives Jazz Pharma facilities Ba2
4/9/2021	BKCVHY	S&P rates Jazz loan BB-

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.